Graves'
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female patients who have undergone or are scheduled to undergo VANS for Graves' disease, thyroid tumors, or parathyroid disorders -Conventional retractor hook group: Patients who underwent VANS between January 1, 2024, and March 31, 2025 -Koplight S group: Patients scheduled to undergo VANS between the approval date by the head of the research institution and March 31, 2026 2. Patients aged 20 to 69 years 3. Patients with a BMI of less than 30
Exclusion criteria
Exclusion criteria: Patients who are determined by the principal investigator or study collaborators to be inappropriate for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time required for flap creation (time from the start of surgery to the completion of flap creation | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of bleeding occurrences during the dissection process of flap creation | — |
Countries
Japan
Contacts
University of Miyazaki Faculty of Medicine Division of the Gastrointestinal, Endocrine and Pediatric Surgery